EHDEN 2020 Webinar Series – The Need for Health Data in the Era of COVID-19: Full Report

10 December 2020, Brussels, Belgium. The European Health Data and Evidence Network (EHDEN) is a pan-European public-private partnership of 22 organisations, led by Erasmus Medical Center and Janssen Pharmaceutica, whose mission is to make large-scale analysis of health data in Europe a reality. Under the aegis of the EU´s Innovative Medicines Initiative and scheduled to run … Read more

EHDEN now working with 62 Data Partners across 16 countries to harmonise clinical data.

08 December 2020, Brussels, Belgium. A critical aspect of the EHDEN project is for it to collaborate with Data Partners, such as hospitals, primary care providers, networks of both, regional datasets, claims databases and cohorts, with a view to harmonising their clinical data locally to a common data model. Key to the success of the … Read more

EHDEN Collaborators Win Big at OHDSI’s Annual Titan Awards

Each year at their annual Symposium, OHDSI recognises collaborators or collaborating institutions that contribute to their mission. Colleagues from across the EHDEN community won Titan awards in all categories at this year’s Symposium, reinforcing the calibre of expertise also within EHDEN as recognised by the OHDSI Community itself.

Data Quality Dashboard Goes Live with the US National COVID Cohort Collaborative

Designed jointly by EHDEN and OHDSI, the Data Quality Dashboard (DQD) debuted last August with the National COVID Cohort Collaborative, which is an initiative funded by the United States National Institutes of Health (NIH). The NIH is the largest biomedical research agency in the world and is part of the United States Department of Health … Read more

New Academy course now available: Phenotype Definition, Characterisation and Evaluation!

We are pleased to announce that we’ve just launched the next course in the EHDEN Academy, teaching you deeper insights into phenotype definition, characterisation and evaluation, using ATLAS, Cohort Diagnostics and the PheValuator tool. This is a fundamental aspect of the OHDSI framework for conducting observational research. In a stepwise approach, you will be guided … Read more

EHDEN Partners collaborate within OHDSI on COVID-19: new paper in Nature on deep phenotyping of COVID-19 patients

Nature COVID-19

Hospitalized COVID-19 Patients Shown To Be Younger, Healthier Than Influenza Patients Per Recent Global Observational Health Study Patients hospitalized with COVID-19 were more likely male, younger and, in both the US and Spain, had fewer comorbidities and lower medication use than hospitalized influenza patients according to a recent study published recently by the Observational Health … Read more

EHDEN Certifies another 5 European SMEs in the mapping of data to the OMOP CDM.

Last week, September 22-23, we had a second training and certification meeting for the SMEs that were selected in our Second open call for SMEs. During these 2 days, another 5 SMEs were certified by EHDEN for their knowledge on standardising health data to the OMOP common data model and the installation of the technical … Read more

Launch of our 3rd open call for data partners

15 September 2020, Brussels, Belgium: The EHDEN Consortium would like to invite all data custodians  of Electronic Health Records, Claims, Hospital and Registry data across Europe to participate in its open call, supporting the mapping of their data to the OMOP common data model. The ambitions of the EHDEN project are high as we aim … Read more

OHDSI and EHDEN Partners Obtain Grant Towards Global Research On COVID-19 Treatments

An international cohort of OHDSI collaborators obtained a grant from the COVID-19 Therapeutics Accelerator to lead an effort to compare the effectiveness of treatments, including corticosteroids such as dexamethasone, under current evaluation for COVID-19 across an international observational data network. The Therapeutics Accelerator is an initiative launched by the Bill & Melinda Gates Foundation, Wellcome, … Read more